Experian Health, MyHealthDirect streamline workflows with patients scheduling appointments

Experian Health, providers of revenue cycle management systems, has launched Patient Schedule, powered by MyHealthDirect, that aims to improve healthcare workflow via patient self-service appointment scheduling.

Patient Schedule was developed for use on both sides of the care continuum, with secure personalized self-service scheduling for patients and calendar maintenance for providers. Experian Health clients are able to improve access to care within its network while gaining insights in where additional capacity is needed.

"MyHealthDirect is proud to collaborate with Experian Health to provide patients with better access to high quality care. Many of the current methods of accessing care are broken and antiquated. We believe that joining forces with Experian Health is a clear path to providing a seamless solution to improve access and patient engagement," said Tom Cox, CEO of MyHealthDirect.

Patients are able to get price estimates, apply for charity care, set payment plans and combine payments through the personalized patient portal. Patient Schedule also allows healthcare systems to follow up on patient appointments, automate scheduling and integrate practice management systems and electronic medical records.

"In today's environment, patients expect on-the-spot scheduling and organizations want a comprehensive solution to coordinate care from start to finish," said Jennifer Schulz, group president of Experian Health. "Patient Schedule empowers patients, providers and physician groups to work closely together to improve patient outcomes. It also gives healthcare providers valuable insight into patient flow across networks to improve retention and loyalty rates, as patients will be able to quickly book and reschedule appointments online and receive reminders for their appointments."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.